Search Login Register

Asbestosis Summary

Description: A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.

Also Known As: Asbestoses; Idiopathic Interstitial Pneumonitis - from Asbestos Exposure; Pulmonary Fibrosis - from Asbestos Exposure

Networked: 933 relevant articles (15 outcomes, 99 trials/studies) for this Disease

Key Drugs and Agents for Asbestosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Asbestos : 10 outcomes 79 studies in 708 results : IBA
  2. Oxygen : 1 outcome 1 study in 9 results : IBA
  3. Collagen : 1 outcome in 11 results : IBA
  4. Biological Markers (Surrogate Marker) : 1 outcome in 4 results : IBA
  5. Gallium : 1 outcome in 4 results : IBA
  6. Antineutrophil Cytoplasmic Antibodies (ANCA) : 1 outcome in 3 results : IBA
  7. Leukotriene B4 : 1 outcome in 2 results : IBA
  8. P-2 (P 2) : 1 outcome in 2 results : IBA
  9. Reducing Agents : 1 outcome in 1 result : IBA
  10. Serum Albumin : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Asbestosis

  1. Pulmonary Fibrosis (Hamman Rich Syndrome)
  2. Silicosis
  3. Pneumoconiosis
  4. Interstitial Lung Diseases (Interstitial Lung Disease)
  5. Inflammation
Show All >>

Key Therapies for Asbestosis

Efficacy Chart >>
  1. Gamma Cameras (Gamma Camera) : 1 outcome in 1 result
  2. Exercise Therapy (Therapy, Exercise) : 2 studies in 2 results
  3. X-Ray Film : 5 results
  4. Thoracoscopes : 1 result
  5. Lung Transplantation : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.